Pantoprazol Dura (Pantoprazole Sodium Sesquihydrate)

Pantoprazole irreversibly inhibits the H+/K+‑ATPase enzyme, commonly called the gastric proton pump, located on the secretory surface of parietal cells. By blocking this final step of acid secretion, the drug raises gastric pH, reducing irritation and allowing damaged mucosal tissue to recover.

The specific dose of Pantoprazol Dura is determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Healthcare professionals follow local prescribing guidelines and adjust the regimen as needed for optimal effectiveness and safety.

Pantoprazole is classified as pregnancy category B in many regions, indicating that animal studies have not shown risk but adequate human studies are lacking. It should be used during pregnancy or lactation only if the potential benefit justifies any potential risk to the fetus or infant, and under medical supervision.

To place an order, submit an enquiry on the Pantoprazol Dura product page at gnhindia.com, providing the required quantity and your institutional details. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then responds with pricing, availability, shipping options and any necessary import documentation.

Pantoprazol Dura, like other PPIs such as omeprazole or esomeprazole, suppresses gastric acid by targeting the proton pump. Pantoprazole is often preferred for its lower potential for drug‑drug interactions, particularly with drugs metabolised by CYP2C19, and it has a stable chemical profile that allows consistent dosing.

Pantoprazol Dura tablets should be stored at temperatures below 25 °C, in the original container to protect them from moisture and direct sunlight. Maintaining these conditions helps preserve the tablet’s potency throughout its shelf life.

Pantoprazol Dura is taken orally, usually as a whole tablet with a glass of water. It can be taken with or without food, but consistent daily timing helps maintain stable acid suppression. Patients should follow the prescribing clinician’s instructions regarding timing and any required fasting.

Serious risks, though uncommon, include severe allergic reactions, Clostridioides difficile‑associated diarrhoea, low magnesium levels, liver enzyme elevations, acute interstitial nephritis and an increased risk of bone fractures with long‑term use. Patients should report any unusual symptoms promptly to their healthcare provider.

Pantoprazol Dura is contraindicated in individuals with known hypersensitivity to pantoprazole or any component of the formulation. Caution is also advised for patients with severe liver disease, those taking certain interacting medications such as clopidogrel, and patients who are pregnant or breastfeeding unless clearly indicated.